
0:00
1:07:22
Moderator: SABCS Co-director Kent Osborne, MD, director of the Dan L Duncan Cancer Center at Baylor College of Medicine
- T-DM1 Improved Overall Survival for Heavily Pretreated Patients With HER2-positive Breast Cancer;
- Phase III BELLE-2 Trial Meets Primary Endpoint of Progression-free Survival;
- No Significant Difference in Recurrence Rates Among Women With DCIS Taking Anastrozole or Tamoxifen; and
- DCIS Patients Receiving Anastrozole Reported Symptoms Different From Those Receiving Tamoxifen.
Otros episodios de "AACR Scientific Podcasts"



No te pierdas ningún episodio de “AACR Scientific Podcasts”. Síguelo en la aplicación gratuita de GetPodcast.



